15
Participants
Start Date
August 1, 2010
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
Idursulfase-IT
Idursulfase-IT once monthly via IDDD.
Elaprase
Weekly IV infusions of commercially available Elaprase.
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
University of North Carolina at Chapel Hill, Chapel Hill
Ann & Robert H Lurie Childrens Hospital of Chicago, Chicago
University of Utah Hospital, Salt Lake City
Legacy Emanuel Hospital, Portland
Seattle Children's Hospital, Seattle
Vanderbilt Children's Hospital, Nashville
British Columbia Children's Hospital, Vancouver
Birmingham Children's Hospital, Birmingham
Lead Sponsor
Takeda
INDUSTRY